Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The underlying mechanism by which ZCCHC7 exerted carcinogenesis and its potential targets in CRC

ABSTRACT: An RIP experiment was performed in RKO cells using ZCCHC7 antibody as bait. The position of peak summit around transcript start sites of genes can predict the interaction sites of protein and gene. We compared the peak summit of RKO WT and RKO ZCCHC7-OE cells to find the differences between RKO WT cells and RKO ZCCHC7-OE cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE234581 | GEO | 2025/03/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

The underlying mechanism by which SRSF1 exerted carcinogenesis and its potential targets in CRC

Project description:An RIP experiment was performed in RKO cells using SRSF1 antibody as bait. The position of peak summit around transcript start sites of genes can predict the interaction sites of protein and gene. We compared the peak summit of RKO WT and RKO ZCCHC7-OE cells to find the differences between RKO WT cells and RKO ZCCHC7-OE cells.

2025-03-01 | GSE234580 | GEO

Exploring the underlying mechanism by which circHNRNPU_603aa exerted carcinogenesis and its potential targets in MM

Project description:A RIP experiment was performed in CAG WT and CAG circHNRNPU_603aa OE cells using HA antibody as bait. The position of peak summit around transcript start sites of genes can predict the interaction sites of protein and gene. We compared the peak summit of CAG WT and CAG circHNRNPU_603aa OE cells to find the differences between CAG WT cells and CAG circHNRNPU_603aa cells.

2022-03-15 | GSE174501 | GEO

The underlying mechanism by which DAZAP1 exerted carcinogenesis and its potential targets in MM

Project description:An RIP experiment was performed in CAG cells using FLAG antibody as bait. The position of peak summit around transcript start sites of genes can predict the interaction sites of protein and gene. We compared the peak summit of CAG EV and CAG DAZAP1 OE cells to find the differences between CAG EV cells and CAG DAZAP1 OE cells.

2024-11-01 | GSE189240 | GEO

The underlying mechanism by which NAT10 exerted carcinogenesis and its potential targets in MM

Project description:An acRIP experiment was performed in KMS28-PE WT and KMS28-PE NAT10-OE cells. We compared the peak summit of KMS28-PE WT and KMS28-PE NAT10 OE cells to find the differences between KMS28-PE WT and KMS28-PE NAT10 OE cells.

2024-06-01 | GSE199524 | GEO

ChIP-seq on ZNF506 overexpression HEK293T to verify ZNF506 binding capacity at PBS-Pro sites.

Project description:To identify ZNF506 genome-wide target sites, we performed ChIP-seq assay and found that ZNF506 binding sites enriched at PBS-Pro-containing ERV subfamilies (ERVPs) and further motif calling analysis showed that ZNF506 binds to PBS-Pro sequences, promoting formation of H3K9me3 modifications at binding regions. And ChIP-seq assay also indicated that the distinction of H3K9me3 signals closed to ZNF506 peak regions between ZNF506 overexpressing (OE) HEK293T cells and ZNF506 Knockout (KO) HEK293T cells was correlated with the different recruitment of corepressor KAP1. The ChIP-seq experiments using GFP antibodies and H3K9me3 antibodies on ZNF506-GFP OE HEK293T cell lines, and ZNF417-GFP OE HEK293T cell lines were used as controls for H3K9me3 ChIP. Also, the ChIP-seq experiments were performed using H3K9me3 antibodies and KAP1 antibodies on ZNF506 KO HEK293T cells and ZNF506 OE HEK293T cells.

2023-07-26 | GSE209826 | GEO

RNA-Seq of human colorectal cancer (CRC) cell lines with or without METTL17 knockdown

Project description:To investigate the mRNA profiling in RKO and SW620 cells with or without shRNA-mediated METTL17 knockdown, we performed RNA-seq with the total RNA extracted from the CRC cells.

2023-08-08 | GSE239325 | GEO

Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type

Project description:Recent preclinical studies suggest that combining MEK and MDM2 inhibition synergize to induce apoptosis in RAS/BRAF-mutant and TP53 wild-type CRC models. In vitro, in RKO cell lines (poorly differentiated colon carcinoma cell line resistant to single agent targeting MDM2 and MEK and BRAF inhibition), the MDM2 plus MEK inhibitor combination generated a synergistic increase in apoptotic index. In vivo, in mice harboring human RKO colon tumor xenografts the combination of MDM2 plus MEK inhibition elicited 93% decreases in tumor volume. This trial is to conduct a single-center, Phase 1 dose escalation study of trametinib combined with HDM201 (a HDM2 inhibitor) in patients with advanced/metastatic RAS/RAF mutant and TP53 wt CRC.

| 2287507 | ecrin-mdr-crc

Gene expression profiling of RKO cells with or without SQLE knockdown.

Project description:RKO cells (WT or SQLE knockdown) were harvested and mRNA were extracted for high-throughput sequencing.

2024-05-20 | GSE232678 | GEO

Expression profiles of piRNAs in Colorectal Cancer (CRC) cell lines

Project description:To investigate the presence and abundance of piRNAs in Colorectal Cancer (CRC), we performed deep-sequencing of the small RNA transcriptome of eight human CRC cell lines (HT-115, Caco-2, SW-1417, SW 403, COLO 205, HT-29, HCT 116 and RKO).

2020-08-06 | E-MTAB-8117 | biostudies-arrayexpress

HIF1A ChIP-seq from HCT116, RKO, A549, and H460 cells in normoxia and hypoxia

Project description:ChIP-seq analysis was used to identify HIF1A binding sites in normoxia and hypoxia in HCT116, RKO, A549, and H460 cells

2021-01-29 | GSE145157 | GEO